Radiopharmaceuticals and Tracers

This channel includes news and new technology innovations for nuclear and molecular imaging agents, radiotracers and radiopharmaceuticals used in PET or SPECT imaging. This includes advances in myocardiac perfusion agents.

News | May 20, 2009
May 20, 2009 – Lantheus Medical Imaging Inc. has signed an agreement with NTP Radioisotopes (Pty) Ltd., a subsidiary...

Siemens Biograph PET/CT series consists of two-, six-, 16-, 40- and 64-slice configurations and provides high-imaging quality and clarity.

Feature | May 19, 2009 | Amy Ballard, MEd, director of research, Arkansas Urology
Myocardial perfusion imaging (MPI) using single photon emission computed tomography/computed tomography (SPECT/CT) is...
Technology | April 02, 2009
Bracco Diagnostics' cardiac PET perfusion imaging agent CardioGen-82, a rubidium Rb 82 generator, is designed to help...
News | January 26, 2009
January 27, 2009 - Lantheus Medical Imaging Inc. said today new data from a prospective, non-randomized, multi-national...
News | January 26, 2009
January 27, 2009 - Babcock & Wilcox Technical Services Group Inc. recently signed an agreement with Covidien to...
News | January 08, 2009
January 9, 2009 - Cardiac nuclear medicine company Positron Corp. said today it will market its complete turnkey...
News | November 02, 2008
November 3, 2008 – PETNET Solutions, a wholly-owned subsidiary of Siemens Medical Solutions USA, and Covidien have...
News | September 23, 2008
September 24, 2008 - Bracco Diagnostics Inc. and Lantheus Medical Imaging Inc. said yesterday they entered into an...
News | September 22, 2008
September 23, 2008 – The FDA has granted approval for Covidien’s generic kit for the preparation of technetium Tc99m...
News | September 08, 2008
September 9, 2008 - Lantheus Medical Imaging Inc. issued a statement assuring regulatory authorities, key customers and...
A comparison of SPECT scanner photo-multiplier technology vs. the newer CZT detector SPECT technology, showing improvement in image clarity.

A comparison of SPECT photo-multiplier technology vs. the newer CZT detector SPECT technology, showing improvement in image clarity. Image from a presentation at the 2017 American Society of Nuclear Cardiology (ASNC) Today meeting.

Feature | Nuclear Imaging | September 03, 2008 | Dave Fornell
An updated version of this story covering more recent PET and SPECT advances is available at this link.   If the case...
News | July 23, 2008
July 24, 2008 - FluoroPharma said it achieved positive phase I test results for BFPET, a novel Fluorine-18 labeled...
News | January 09, 2008
January 10, 2008 – Molecular imaging agents development will enhance the use of single photon emission computed...
News | December 10, 2007
December 11, 2007 – Due to the loss of more than 50 percent of the North American Mo-99 supply and its impact on the...
News | October 04, 2006
Clinical trials to study the efficacy of a novel cardiac viability imaging agent is now underway. FluoroPharma, Inc.,...